Davis P L, Yamamoto T, Williams B T. "一种的合成方法" [P]. US Patent, US 9840015 B2, 2020-05-24.
发明人胡光,孙丽萍,陈志强. "Method for the Synthesis of 2-((1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methyl)-3a,7a-dihydro-1H-isoindole-1,3(2H)-dione" [P]. 中国发明专利, 专利号 CN 111153957 A, 授权公告日 2025-10-23.
发明人孙丽萍,何建平,胡光. "A Process for Preparing High-Purity 2-((1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methyl)-3a,7a-dihydro-1H-isoindole-1,3(2H)-dione" [P]. 中国发明专利, 专利号 CN 108682879 B, 授权公告日 2018-08-15.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2013, 784, 7401-7425.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2018, 1288, 4643-4672.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 2-((1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methyl)-3a,7a-dihydro-1H-isoindole-1,3(2H)-dione Using HRMS and NMR". Anal. Chim. Acta, 2021, 2202, (4), 265-284.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2011, 1938, (4), 1654-1669.